Cytotoxic agents containing novel potent taxanes and their therapeutic use
AssigneeImmunoGen, Inc.
InventorsErkan Baloglu, Michael Miller, Ravi V.J. Chari
Life of this patent
Estimating the term…
Loading patent…
AssigneeImmunoGen, Inc.
InventorsErkan Baloglu, Michael Miller, Ravi V.J. Chari
Estimating the term…
Included within the scope of the present invention are potent taxanes containing a linking group. Also included is a cytotoxic agent comprising one or more taxanes linked to a cell binding agent. A therapeutic composition for inducing cell death in selected cell populations comprising: (A) a cytotoxic amount of one or more taxanes covalently bonded to a cell binding agent through a linking group, and (B) a pharmaceutically acceptable carrier, diluent or excipient is also included. A method for inducing cell death in selected cell populations comprising contacting target cells or tissue containing target cells with an effective amount of a cytotoxic agent comprising one or more taxanes linked to a cell binding agent is included as well.
A compound represented by formula (I):
A compound represented by formula (I):
The compound represented by Formula (I),
A compound represented by formula (I):
A compound represented by formula (I):
A compound represented by formula (I):
Dependencies are inferred from the claim text.